Q: In the last question related to CRH, you indicated that it had a forward PE Ratio of over 40X, and a P/BV ratio of 14X.
That sounds very expensive, even if it is a high growth stock. How is this any different than some of the marijuana stocks you have indicated we should avoid due to extended valuations?
I guess my question is - how do you know when a stock is too expensive? Is there a metric one can use that says x% revenue growth can be priced as high as 'y' P/E or 'z' P/BV?
That sounds very expensive, even if it is a high growth stock. How is this any different than some of the marijuana stocks you have indicated we should avoid due to extended valuations?
I guess my question is - how do you know when a stock is too expensive? Is there a metric one can use that says x% revenue growth can be priced as high as 'y' P/E or 'z' P/BV?